Should C-reactive protein be added to metabolic syndrome and to assessment of global cardiovascular risk?

Paul M. Ridker, Peter W F Wilson, Scott M Grundy

Research output: Contribution to journalReview articlepeer-review

523 Scopus citations

Fingerprint

Dive into the research topics of 'Should C-reactive protein be added to metabolic syndrome and to assessment of global cardiovascular risk?'. Together they form a unique fingerprint.

Medicine & Life Sciences